100000 - Document - Cover Page
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Consolidated Statements of Profit or (Loss) and Other Comprehensive Income or (Loss)
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Statement - Consolidated Statements of Profit or (Loss) and Other Comprehensive Income or (Loss) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - Consolidated Statements of Profit or (Loss) and Other Comprehensive Income or (Loss) 2
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Consolidated Statements of Financial Position
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Consolidated Statements of Changes in Equity
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Statement - Consolidated Cash Flow Statements
link:presentationLink
link:calculationLink
link:definitionLink
100070 - Disclosure - Insider Trading Policies and Procedures
link:presentationLink
link:calculationLink
link:definitionLink
100080 - Disclosure - General Information
link:presentationLink
link:calculationLink
link:definitionLink
100090 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
100100 - Disclosure - Significant Accounting Judgements and Estimates
link:presentationLink
link:calculationLink
link:definitionLink
100110 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
100120 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
100130 - Disclosure - Employee costs
link:presentationLink
link:calculationLink
link:definitionLink
100140 - Disclosure - Share-based Payment
link:presentationLink
link:calculationLink
link:definitionLink
100150 - Disclosure - Principal Accountant Fees and Services
link:presentationLink
link:calculationLink
link:definitionLink
100160 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax
link:presentationLink
link:calculationLink
link:definitionLink
100170 - Disclosure - Intangible Assets
link:presentationLink
link:calculationLink
link:definitionLink
100180 - Disclosure - Property, Plant and Equipment
link:presentationLink
link:calculationLink
link:definitionLink
100190 - Disclosure - Investment in Associate
link:presentationLink
link:calculationLink
link:definitionLink
100200 - Disclosure - Inventories
link:presentationLink
link:calculationLink
link:definitionLink
100210 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
100220 - Disclosure - Contract liabilities
link:presentationLink
link:calculationLink
link:definitionLink
100230 - Disclosure - Provisions
link:presentationLink
link:calculationLink
link:definitionLink
100240 - Disclosure - Financial Assets and Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
100250 - Disclosure - Financial Risk Management
link:presentationLink
link:calculationLink
link:definitionLink
100260 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
100270 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
100280 - Disclosure - Investments in Group Enterprises
link:presentationLink
link:calculationLink
link:definitionLink
100290 - Disclosure - Ownership
link:presentationLink
link:calculationLink
link:definitionLink
100300 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
100310 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
100320 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100330 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100340 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100350 - Disclosure - Employee Costs (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100360 - Disclosure - Share-based Payment (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100370 - Disclosure - Principal Accountant Fees and Services (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100380 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100390 - Disclosure - Intangible Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100400 - Disclosure - Property, Plant and Equipment (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100410 - Disclosure - Investment in Associate (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100420 - Disclosure - Inventories (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100430 - Disclosure - Provisions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100440 - Disclosure - Financial Assets and Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100450 - Disclosure - Financial Risk Management (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100460 - Disclosure - Investments in Group Enterprises (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100470 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100480 - Disclosure - Summary of Significant Accounting Policies - Schedule of Asset's Expected Useful Life (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100490 - Disclosure - Significant Accounting Judgements and Estimates - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100500 - Disclosure - Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100510 - Disclosure - Revenue - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100520 - Disclosure - Revenue - Schedule of Revenue Recognized in Consolidated Statements of Profit or Loss (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100530 - Disclosure - Segment Information - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100540 - Disclosure - Segment Information - Summary of Intangible Assets, and Property, Plant and Equipment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100550 - Disclosure - Employee Costs - Summary of Employee Cost (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100560 - Disclosure - Employee Costs - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100570 - Disclosure - Share-Based Payment - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100580 - Disclosure - Share-Based Payment - Summary Of Share Based Payment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100590 - Disclosure - Share-Based Payment - Summary Of Share Based Payment (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100600 - Disclosure - Share-based Payment - Schedule of Warrant Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100610 - Disclosure - Share-based Payment - Schedule of Warrant Activity (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100620 - Disclosure - Share-based Payment - Schedule of Weighted Average Exercise Price and Weighted Remaining Contractual Life for Outstanding Warrants (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100630 - Disclosure - Share-based Payment - Summary of Fair Values for Warrant Grants (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100640 - Disclosure - Principal Accountant Fees and Services - Summary of Principal Accountant Fees and Services (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100650 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Summary of Tax on Profit/Loss and Deferred Tax (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100660 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Summary of Tax on Profit/Loss and Deferred Tax (Parenthetical) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100670 - Disclosure - Tax on Profit/(Loss) for the Year and Deferred Tax - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100680 - Disclosure - Intangible Assets - Summary of Goodwill (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100690 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant and Equipment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100700 - Disclosure - Property, Plant and Equipment - Summary of Depreciations Charges (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100710 - Disclosure - Investment in Associate - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100720 - Disclosure - Investment in Associate - Schedule of Financial Information of Investment in VISEN (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100730 - Disclosure - Investment in Associate - Equity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100740 - Disclosure - Inventories - Summary of Inventories Explanatory (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100750 - Disclosure - Inventories - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100760 - Disclosure - Leases - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100770 - Disclosure - Leases - Summary of Development In Lease Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100780 - Disclosure - Leases - Summary of Expenses, Relating To Lease Activities In The Consolidated Statements (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100790 - Disclosure - Contract Liabilities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100800 - Disclosure - Provisions - Summary of Development in Provisions (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100810 - Disclosure - Financial Assets and Liabilities - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100820 - Disclosure - Financial Assets and Liabilities - Schedule of Financial assets and Financial Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100830 - Disclosure - Financial Assets and Liabilities - Schedule of Finance Income and Finance Expenses (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100840 - Disclosure - Financial Assets and Liabilities - Summary of Expenses, Relating To Lease Activities In The Consolidated Statements (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100850 - Disclosure - Financial Assets and Liabilities - Summary of Development in Borrowings Arising from Financing Activities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100860 - Disclosure - Financial Assets and Liabilities - Summary of Fair Value Hierarchy (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100870 - Disclosure - Financial Assets and Liabilities - Development in Level 3 Fair Value Remeasurements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100880 - Disclosure - Financial Risk Management - Summary of Number of Shares (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100890 - Disclosure - Financial Risk Management - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100900 - Disclosure - Financial Risk Management - Summary of Holding of Treasury Shares (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100910 - Disclosure - Financial Risk Management - Schedule of Foreign Currency Sensitivity Analysis (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100920 - Disclosure - Financial Risk Management - Summary of Rate Structure of Marketable Securities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100930 - Disclosure - Financial Risk Management - Schedule of Marketable Securities Specified By Investment Grade Credit Rating (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100940 - Disclosure - Financial Risk Management - Summary of Marketable securities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100950 - Disclosure - Financial Risk Management - Summary of Contractual Cash Flows for Financial Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100960 - Disclosure - Commitments and Contingencies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100970 - Disclosure - Investments in Group Enterprises - Summary of Investments in Group Enterprises (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100980 - Disclosure - Ownership - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
100990 - Disclosure - Subsequent Events - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
Share-based Incentive Programs
Description of accounting policy for employee benefits [text block]
All levels of fair value hierarchy [member]
Entity Address, City or Town
Currently stated [member]
Currently stated [member]
Current borrowings
Borrowings
Subclassifications of assets, liabilities and equities [abstract]
Increase (decrease) through changes in fair values, liabilities arising from financing activities
Separation of fair value
Schedule of Weighted Average Exercise Price and Weighted Remaining Contractual Life for Outstanding Warrants
Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]
Weighted Average Exercise, Granted
Granted during the year
Weighted average exercise price of other equity instruments granted in share-based payment arrangement
Transferred
Increase (decrease) through transfers, intangible assets other than goodwill
Payment of interest
Interest paid, classified as financing activities
Interest paid
Other temporary differences, liabilities
Other temporary differences, liabilities
Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised
Summary of Marketable securities
Disclosure Detailed Information About Marketable Securities [Text Block]
Disclosure detailed information about marketable securities.
Categories of related parties [axis]
Categories of related parties [axis]
Income tax payables
Current tax liabilities
Impairment charge
Impairment loss recognised in profit or loss, intangible assets and goodwill
Impairment loss recognised in profit or loss, intangible assets and goodwill
Unobservable inputs [axis]
Depreciation and impairment [member]
Accumulated depreciation, amortisation and impairment [member]
Impairment charge
Impairment loss recognised in profit or loss, property, plant and equipment
Impairment loss recognised in profit or loss, property, plant and equipment
Disclosure of fair value measurement of liabilities [abstract]
Gross profit
Gross profit
Gross profit
Borrowings threshold percentage of sale price per share for redemption
Borrowings Threshold Percentage Of Sale Price Per Share For Redemption
Borrowings threshold percentage of sale price per share for redemption.
Fair value hierarchy carrying amount.
Fair Value Hierarchy Carrying Amount [member]
Carrying amount [member]
Company's share of equity after eliminations
Share of equity after eliminations
Share of equity after eliminations.
Financial Assets Duration Period
Realized Duration of Financial Assets Explanatory
Realized duration of financial assets explanatory.
Total revenue
Total revenue
Revenue
Revenue
Business Contact [member]
Business Contact [Member]
Royalty payment ending period
Royalty Payment Ending Period
Royalty payment ending period.
"Right-to-use" licenses
Licence fee income
Licenses
Financial Assets and Liabilities
Disclosure of financial instruments [text block]
Amendment Flag
Royalty funding
Royalty funding.
Provisions [abstract]
Collaboration partner one [Member]
Collaboration Partner One.
Diluted earnings/(loss) per share
Total diluted earnings (loss) per share
Diluted earnings (loss) per share
Purchase of marketable securities
Purchase of available-for-sale financial assets
Timing of transfer of goods or services [axis]
Disclosure of employee compensation costs [line items]
Disclosure of employee compensation costs [line items]
Disclosure of employee compensation costs.
Lease liabilities [member]
Lease liabilities
Carrying amount of current lease liabilities
Current lease liabilities
Depreciation
Depreciation, right-of-use assets
Foreign exchange translation
Increase (decrease) through net exchange differences, other provisions
Weighted Average Duration Of Marketable Securities Explanatory
Weighted average duration of marketable securities explanatory.
Weighted average duration of marketable securities
Settled during the period
Settled during the period
Number Of Other Equity Instruments Settled In Share Based Payment Arrangement
Number of other equity instruments settled in share based payment arrangement.
Vested at the reporting date
Weighted average exercise price of other equity instruments vested in sharebased payment arrangement
Weighted average exercise price of other equity instruments vested in share-based payment arrangement
Tax on Profit/(Loss) for the Year and Deferred Tax
Disclosure of income tax [text block]
Categories of financial assets [abstract]
Financial assets by category
Transferred during the period
Number Of Other Equity Instruments Transferred In Share Based Payment Arrangement
Number of other equity instruments transferred in share based payment arrangement.
Transferred during the period
Later than one year [member]
Treasury Shares Holding In Percentage Of Total Outstanding Shares
Treasury shares holding in percentage of total outstanding shares.
Ending balance (Holding in % of total outstanding shares)
Beginning balance (Holding in % of total outstanding shares)
Adjustments For Non Cash Consideration Regarding Revenue
Adjustments for non cash consideration regarding revenue.
Non-cash consideration relating to revenue
Disclosure of financial instruments by type of interest rate [abstract]
Disclosure of associates [abstract]
Retrospective application and retrospective restatement [axis]
Retrospective application and retrospective restatement [axis]
Summary of Expenses, Relating To Lease Activities In The Consolidated Statements
Disclosure of Expenses Relating To Lease Activities In The Consolidated Statements
Disclosure Of Expenses Relating To Lease Activities In The Consolidated Statements.
Foreign exchange and other adjustments loss (net)
Net foreign exchange loss
Profit / (loss) for the year from continuing operations
Profit Loss For The Year
Profit loss for the year.
Applicable tax rate
Applicable tax rate
General Information
Disclosure of general information about financial statements [text block]
Classes of assets [axis]
Classes of assets [axis]
Deferred tax expense (income) [abstract]
Domicile
Country of incorporation of associate
Categories of current financial assets [abstract]
Line items by function [member]
Tax losses carryforwards
Tax Losses Carryforwards
Tax Losses Carryforwards.
Geographical areas [member]
Geographical areas [member]
Current tax, adjustments to prior years
Adjustments for current tax of prior periods
Items that may be reclassified subsequently to profit or loss:
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Financial assets
Financial assets at beginning of period
Financial assets at end of period
Total financial assets
Conversion price per share
Conversion Price Per Share
Conversion price per share.
Goods or services transferred over time [member]
Enforceable LeaseTerm
Enforceable leaseterm.
Enforceable Lease Term
Classes of property, plant and equipment [axis]
Classes of property, plant and equipment [axis]
Disclosure of maturity analysis for derivative financial liabilities [table]
Losses on change in fair value of derivatives
Losses on change in fair value of derivatives
Fair value loss, derivatives
Receivables
Description of accounting policy for loans and receivables [text block]
Auditor Firm ID
Investments In Group Enterprises [Abstract]
Investments in group enterprises.
Reserve of treasury shares.
Reserve of Treasury Shares
Treasury shares reserve
Lease Term
Lease Term
LeaseTerm.
Historical volatility for shares, measurement input [member]
Summary of Employee Cost
Disclosure Of Detailed Information About Employee Cost Explanatory [Text Block]
Disclosure of detailed information about employee cost.
Vested at the reporting date
Exercised during the year
Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement
Entity Addresses, Address Type [Axis]
Categories Of Shares Based Payments [Domain]
Categories Of Shares Based Payments [Domain]
Contract liabilities are expected to be recognized as revenue
Transaction price allocated to remaining performance obligations
Property, plant and equipment
Property, plant and equipment at beginning period
Property, plant and equipment at ending period
Property, plant and equipment
Total property, plant and equipment
Profit or loss [abstract]
Summary of Contractual Cash Flows for Financial Liabilities
Contractual cashflows for financial liabilities.
Contractual Cashflows For Financial Liabilities [Text Block]
Granted in 2023 [Member]
Granted in 2023 [Member]
Granted in 2023 member.
Current financial liabilities
Total current financial liabilities
Current liabilities
Disclosure of detailed information about borrowings [abstract]
Borrowings
Total borrowings
Beginning of period
End of period
Lease Commence Period
Lease commence period.
Inventories
Description of accounting policy for measuring inventories [text block]
Summary of Inventory Disclosure [Table]
Summary of inventory disclosure .
All other fees
Auditor's remuneration for other services
Ascendis Pharma Bone Diseases A/S [member]
Ascendis Pharma Bone Disease AS [member]
Ascendis Pharma bone disease AS.
Entities affiliated with RA capital management LLC [member]
Entities Affiliated With RA Capital Management LLC [member]
Entities affiliated with RA capital management LLC.
High Grade [Member]
High grade member.
Interest rate types [member]
Interest rate types [member]
Summary of Goodwill and Software
Disclosure of reconciliation of changes in intangible assets and goodwill [text block]
Disclosure of terms and conditions of share-based payment arrangement [abstract]
Total non-current assets
Non-current assets
Non-current assets
Entity Incorporation, State or Country Code
Disclosure of maturity analysis for derivative financial liabilities [abstract]
Ascendis Pharma Europe A/S [member]
Ascendis Pharma Europe A/S.
Summary Of Rate Structure Of Marketable Securities
Disclosure of financial instruments by type of interest rate [text block]
Summary of Development In Lease Liabilities
Disclosure of development in lease liabilities [Text Block]
Disclosure of development in lease liabilities.
Summary of Development in Borrowings Related to Financing Activities
Tax fees
Auditor's remuneration for tax services
Vesting [Member]
Vesting
Contract liabilities
Disclosure of revenue from contracts with customers [text block]
Inventory write-downs
Inventory write-down
Two Thousand And Twenty Three To Two Thousand And Twenty Six [Member]
Two thousand and twenty three to two thousand and twenty six
T Rowe Price Associates Inc [member]
T Rowe Price AssociatesInc [member]
T Rowe Price Associates Inc.
Share capital [member]
Share capital [member]
Ascendis Pharma Ophthalmology Division A/S [member]
Ascendis Pharma Ophthalmology Division AS [member]
Ascendis Pharma Ophthalmology Division AS.
Foreign Currency Risk [axis]
Foreign Currency Risk [axis]
Foreign currency risk.
Convertible Senior Notes
Convertible senior notes
Convertible Senior Notes
Convertible senior notes.
Operating activities
Cash flows from (used in) operating activities [abstract]
Granted before January 1, 2021 [Member]
Granted Before January 1, 2021 [Member]
Granted before January 1, 2021 member.
Restricted Stock Units and Performance Stock Unit [Member]
Restricted Stock Units and Performance Stock Unit [Member]
Restricted stock units and performance stock unit.
Corporate bonds [Member]
Corporate bonds [Member]
Corporate bonds [Member].
Investment in associate
Purchase of interests in associates
Insider Trading Policies and Procedure [Abstract]
Insider trading policies and procedure.
Categories of financial liabilities [axis]
Categories of financial liabilities [axis]
Investment in associate
Investments in associates reported in separate financial statements
Inventories
Current inventories
Total inventories, net
Goods or services transferred at point in time [member]
Share of profit/(loss) of associate
Share of profit/(loss) of associate
Share of profit (loss) of associates accounted for using equity method
Disclosure of non-adjusting events after reporting period [abstract]
Transactions and outstanding balances as of December 31
Transactions and outstanding balances [Abstract]
Transactions and outstanding balances.
Disclosure Of Financial Instruments And Financial Risk Management [text block]
Entire disclosure of financial instruments and financial risk management.
Financial Risk Management
Rendering of services
Revenue from rendering of services
Borrowings threshold trading days for redemption
Borrowings Threshold Trading Days For Redemption
Borrowings Threshold Trading Days For Redemption.
Computer software [member]
Computer software [member]
Attributable to owners of the Company
Comprehensive income, attributable to owners of parent
Disclosure Of Financial Assets And Liabilities [text block]
Disclosure Of Financial Assets And Liabilities [text block]
Schedule of Financial Assets and Financial Liabilities
Increase through cash contributions
Increase (decrease) in number of ordinary shares issued
Prepayments
Adjustments for decrease (increase) in prepaid expenses
Contract Liabilities
Description of accounting policy for deferred revenues and contract liabilities explanatory [text block]
Description of accounting policy for deferred revenues and contract liabilities.
Inventories
Adjustments for decrease (increase) in inventories
Foreign exchange and other adjustments gain (net)
Net foreign exchange gain
Foreign exchange adjustment
Foreign exchange gain (loss)
Net foreign exchange gain (loss)
Vesting period
Sharebased Payment Arrangement Vesting Period
Share-based payment arrangement vesting period.
US dollars to Euro [member]
US dollars to Euro [member]
US dollars to Euro.
Treasury shares holding in percentage transferred under stock incentive programs.
Treasury Shares Holding In Percentage Transferred under stock incentive programs
Transferred under stock incentive programs (Holding in 1% total outstanding shares)
Perentage of sale to commercial customers
Percentage of entity's revenue
Percentage of entity's revenue
Disclosure of terms and conditions of share-based payment arrangement [line items]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Net proceeds
Increase (decrease) through effect of proceeds, liabilities arising from financing activities.
Increase Decrease Through Effect Of Proceeds, Liabilities Arising From Financing Activities
Licenses of IP [Member]
Licenses of IP [Member]
Licenses of IP member.
Finance Income and Expenses
Description of accounting policy for finance income and costs [text block]
Borrowings
Contractual undiscounted cashflow of borrowings.
Contractual undiscounted cashflow of borrowings
Total borrowings
Weighted Average Duration Of Marketable Securities Noncurrent Explanatory
Weighted average duration of Marketable securities noncurrent explanatory.
Weighted average duration of marketable securities noncurrent
Non-current financial marketable securities
Marketable securities
Non-current financial assets available-for-sale
Weighted average remaining life for outstanding warrants
Weighted average remaining contractual life of outstanding share options
After 5 years [member]
Later than three years and not later than five years [member]
Significant Accounting Judgements and Estimates
Disclosure of accounting judgements and estimates [text block]
Non-derivative financial liabilities, undiscounted cash flows
Total financial liabilities
Vested at the reporting date
Number of other equity instruments vested in share-based payment arrangement
Number of other equity instruments vested in share-based payment arrangement.
Weighted average number of shares used for calculation (basic and diluted)
Weighted average number of ordinary shares used in calculating basic earnings per share
Associates [member]
Associates [member]
The increase (decrease) in liabilities arising from financing activities resulting from the effect of accretion of interest.
Increase Decrease Through Effect Of Accretion of Interest Liabilities Arising From Financing Activities
Accretion of interest
Wages and salaries
Wages and salaries
Expected revenue recognition period from non-current contract liabilities .
Expected Revenue Recognition Period From Non-current Contract Liabilities
Expected revenue recognition period from non-current contract liabilities .
Acquired from third-parties (Holding)
Increase Decrease In Treasury Shares Acquired From Third Parties
Increase decrease In treasury shares acquired from third parties.
Acquired from third-parties (Holding)
Contract Liabilities [Line Items]
Contract liabilities [Line Items].
VISEN Pharmaceuticals [member]
V I S E N Pharmaceutical [Member]
VISEN pharmaceuticals.
VISEN
Westfield Capital Management Company, L.P [member]
Westfield Capital Management Company, L.P., USA [member]
Westfield Capital Management Company, L.P., USA [member]
City Area Code
Impairment
Description of accounting policy for impairment of assets [text block]
Ending balance
Beginning balance
Provisions
Current provisions
Total current provisions
Convertible Senior Notes and Embedded Derivative Liabilities
Description of accounting policy for borrowings [text block]
New IFRSs [axis]
New IFRSs [axis]
Germany [member]
Germany [member]
Germany [Member].
Increase/(decrease) in cash and cash equivalents
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes
Optional Lease Extension Period
Lease Extension Period
Lease Extension Period.
Classes of employee benefits expense [abstract]
Net profit/(loss) for the period
Net profit/(loss) for the year
Net profit/(loss) for the year
Profit (loss)
Carrying amount of lease liabilities
Lease liabilities
Beginning of period
End of period
Lease liabilities
Total lease liabilities
Document Period End Date
Proceeds from issue of bonds, notes and debentures
Proceeds From Issuance Of Notes
Disclosure of detailed information about financial instruments [abstract]
Nominal positions
Nominal Value Amount
Nominal Value Amount
Disclosure Detailed Information About Marketable Securities [Line Items]
Disclosure Detailed Information About Marketable Securities LineItems.
Financial liabilities
Categories of financial liabilities [abstract]
Financial liabilities by category
Exercise price
Exercise price of outstanding share options
Sharebased Payment Arrangement, Restricted Stock Unit, Activity [Table]
Share-based payment arrangement, restricted stock unit, activity.
Statement of profit or (loss)
Profit (loss) [abstract]
Disclosure Of Holding Of Treasury Shares [Line Items]
Disclosure of holding of treasury shares.
Disclosure of detailed information about intangible assets [line items]
Disclosure of detailed information about intangible assets [line items]
Sales rebates and product returns in U.S. market [member]
Sales Rebates And Product Returns In U.S. Market [Member]
Sales rebates and product returns in U.S. market.
Investment in Associate
Disclosure of associates [text block]
Schedule of Financial Assets and Financial Liabilities
Disclosure of offsetting of financial assets and financial liabilities [text block]
Disclosure of financial instruments by type of interest rate [table]
Non-current financial liabilities
Total non-current financial liabilities
Non-current liabilities
Entity's total for subsidiaries [member]
Entity's total for subsidiaries [member]
Tax on profit/(loss) for the year:
Current tax expense (income) and adjustments for current tax of prior periods [abstract]
Denmark [member]
DENMARK
Statement of comprehensive income [abstract]
Prepayments
Current prepayments
Total current prepayments
Disclosure Of Marketable Securities Specified By Investment Grade Credit Rating [Abstract]
Disclosure of marketable securities specified by investment grade credit rating.
Share nominal value
Nominal value common shares
Par value per share
Contract liabilities
Current contract liabilities
Total current contract liabilities
Sharebased Payment Arrangement, Restricted Stock Unit, Activity [Line Items]
Share-based payment arrangement, restricted stock unit, activity.
Disclosure of detailed information about depreciations charges [Table]
Cash flows from/(used in) financing activities
Cash flows from (used in) financing activities
Net cash flows from (used in) financing activities
Disclosure of associates and joint ventures [line items]
Disclosure of associates and joint ventures [line items]
Line items represent concepts included in a table. These concepts are used to disclose reportable information about associate and joint ventures associated with domain members defined in one or many axes of the table.
Acquisition of property, plant and equipment member.
Acquisition of Property, Plant and Equipment [Member]
Acquisition of property, plant and equipment [member]
Cash Flow Statement
Description of accounting policy for cash flows [text block]
Royalty funding
Royalty funding liabilities
Royalty funding liabilities.
Disclosure of fair value measurement of liabilities [table]
Entity Address, Postal Zip Code
American Depositary Shares [member]
American Depositary Shares [Member]
American depositary shares member.
Trade payables
Trade and other payables
Total trade and other payables
Trade receivables
Trade receivables from associate
Frazier Life Sciences of Eyconis, Inc. [member]
Frazier Life Sciences of Eyconis, Inc.
Document Fiscal Period Focus
Geographical areas [axis]
Geographical areas [axis]
Adjustments for non-cash items:
Adjustments to reconcile profit (loss) [abstract]
Proceeds from disposal of property, plant and equipment
Proceeds from sales of property, plant and equipment, classified as investing activities
Depreciation
Adjustments for depreciation expense
Entities affiliated with FMR LLC [member]
Entities Affiliated With FMR LLC [member]
Entities affiliated with FMR LLC.
Presentation of leases for lessee [abstract]
Leases
Description of accounting policy for leases [text block]
Shareholders' Equity
Description of accounting policy for issued capital [text block]
Disclosure of quantitative information about right-of-use assets [table]
Reserve of share-based payments
Share-based payment reserve
Total financial liabilities
Contractual Undiscounted Cashflow Of Financial Liabilities
Contractual undiscounted cashflow of financial liabilities.
Net additions
Total additional provisions, other provisions
Additional provisions, other provisions
Basic earnings/(loss) per share
Total basic earnings (loss) per share
Basic earnings (loss) per share
Two Thousand And Twenty Two [Member]
Two thousand and twenty two.
Recognized as revenue
Revenue from contracts with customers
Securities Act File Number
Entity File Number
Principal place of business
Principal place of business of associate
Basic EPS
Description of accounting policy for earnings per share [text block]
Acquired from third-parties (Holding in 1% total outstanding shares)
Treasury Shares Holding In Percentage Of Total Outstanding Shares Acquired From Third Parties
Treasury Shares Holding In Percentage Of Total Outstanding Shares Acquired From Third-Parties.
Acquired from third-parties (Holding in % of total outstanding shares)
Property, Plant and Equipment
Disclosure of property, plant and equipment [text block]
Liabilities arising from financing activities [member]
Liabilities arising from financing activities [member]
Revenue
Description of accounting policy for recognition of revenue [text block]
Executive Board [member]
Executive Board [member]
Executive board.
Effective tax rate
Average effective tax rate
Total average effective tax rate
Financial instruments, class [member]
Trade payables and accrued expenses
Current trade payables
Weighted Average Exercise, Outstanding
Beginning balance
Ending balance
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement
Related Party Transactions
Disclosure of related party [text block]
Categories of non-current financial liabilities [abstract]
Classified in the statement of financial position
Share Premium [member]
Share premium [member]
Commercial papers [Member]
Commercial papers [Member]
Commercial papers [Member].
Reconciliation of changes in fair value measurement, liabilities [abstract]
Counterparties [member]
Development expenditures (software)
Payments for development project expenditure
Summary Of Holding Of Treasury Shares
Disclosure of treasury shares [text block]
Auditor Location
Investments in Group Enterprises
Disclosure of interests in other entities [text block]
Ascendis Pharma Endocrinology Division A/S [member]
Ascendis Pharma Endocrinology Division AS [member]
Ascendis Pharma endocrinology division AS.
Elimination of internal profit recognized
Elimination of Internal Profit Recognized
Elimination of internal profit recognized.
Interest income
Interest income
Bank deposits
Balances with banks
Sale or issue of treasury shares
Transfer under stock incentive programs
Share based Payment Arrangement, Award type [Axis]
Share-based payment arrangement, award type.
Diluted EPS
Description of accounting policy for diluted earnings per share explanatory
Description of accounting policy for diluted earnings per share.
Disposals
Disposals, property, plant and equipment
Disclosure of detailed information about property, plant and equipment [line items]
Disclosure of detailed information about property, plant and equipment [line items]
Warrants Granted From December 2021 [member]
Warrants Granted From December 2021 [Member]
Warrants Granted From December 2021 [Member]
Cash flows from/(used in) investing activities
Cash flows from (used in) investing activities
Net cash flows from (used in) investing activities
Disclosure of associates [line items]
Disclosure of Associate [Line Items]
Disclosure of associate [Line Items]
Summary of Share Based Payment
Sharebased Payment Arrangement, Restricted Stock Unit, Activity [Text Block]
Sharebased payment arrangement, restricted stock unit, activity.
Attributable to owners of the Company
Profit (loss), attributable to owners of parent
Other equipment [member]
Other property, plant and equipment [member]
Property, plant and equipment [abstract]
Entities affiliated with Artisan Partners Limited Partnership [member]
Entities Affiliated With Artisan Partners Limited Partnership [Member]
Entities Affiliated With Artisan Partners Limited Partnership.
Amortization Charge
Amortisation, intangible assets other than goodwill
Amortisation, intangible assets other than goodwill
Net proceeds after deduting offering expenses
Proceeds From Royalty Funding Liabilities Excluding Offering Expenses
Proceeds from royalty funding liabilities excluding offering expenses.
Disclosure of maturity analysis of operating lease payments [line items]
Income tax receivables
Current tax assets, current
Insider Trading Policies and Procedure Adopted [Flag]
Insider trading policies and procedure adopted.
Investment in Associates
Description of accounting policy for investment in associates [text block]
Statement of financial position
Statement of financial position [abstract]
Lease liabilities
Carrying amount of non-current lease liabilities
Non-current lease liabilities
North America [member]
North America1 [Member]
North America 1 Member.
Reversal of gain and loss on disposal of property, plant and equipment
Reversal Of Gain Loss On Property Plant And Equipment
Reversal of gain loss on property plant and equipment.
Borrowings in arrears default payment start date
Borrowings In Arrears Default Payment Start Date
Borrowings in arrears default payment start date.
Antidilutive Securities Not Included In Diluted Earnings Per Share [Axis]
Antidilutive securities not included in diluted earnings per share.
Prepayments
Description of accounting policy for prepayments explanatory
Description of accounting policy for prepayments explanatory.
Description of accounting policy for allowance for expected credit losses on financial assets.
Description of Accounting Policy for Allowance for Expected Credit Losses on Financial Assets [text block]
Allowance for Expected Credit Losses on Financial Assets
Income Statement [Axis]
Income Statement [Axis]
Income statement [Axis].
Summary of Property, Plant and Equipment
Disclosure of detailed information about property, plant and equipment [text block]
Research and development costs [member]
Research and development expenses [member]
Research And Development Costs [Member]
Research and development costs.
Disclosure of reconciliation of changes in goodwill [table]
Financing activities
Cash flows from (used in) financing activities [abstract]
Domicile
Country of incorporation of subsidiary
Statement of cash flows [abstract]
Total non-current liabilities
Non-current liabilities
Non-current liabilities
Level 1 of fair value hierarchy [member]
Level 1 [member]
Disclosure of maturity analysis for derivative financial liabilities [line items]
Agency bonds [Member]
Agency bonds [Member]
Agency bonds [Member].
Financial liabilities measured at amortized cost
Financial liabilities at amortised cost
Financial liabilities measured at amortized cost
Board of Directors [member]
Board Of Directors [member]
Board of directors.
Share capital
Issued capital
Total issued capital
Disclosure of detailed information about intangible assets [abstract]
Non-current segment assets
Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts
Granted In 2022.
Granted In 2022 [Member]
Schedule of Finance Income and Finance Expenses
Disclosure of finance income (cost) [text block]
Revenue
Disclosure of revenue [text block]
Current Fiscal Year End Date
Auditor's remuneration [abstract]
Receivables due from associates
Receivable from associate
2026
Two Thousand And Twenty six [Member]
Two thousand and twenty six.
Number of shares issued
Share capital beginning of year
Share capital end of year
Number of shares issued
Total number of shares issued
Principal Accountant Fees and Services
Disclosure of auditors' remuneration [text block]
Interest expenses
Interest expense
Disclosure Of Marketable Securities Specified By Investment Grade Credit Rating [Line Items]
Disclosure of marketable securities specified by investment grade credit rating.
Other receivables
Other current receivables
Finance income expense [abstract]
Finance income expense [abstract].
Performance obligations [member]
Disclosure of Operating Segments [abstract]
Revenue [abstract]
Acquisition of treasury shares
Purchase of treasury shares
Document Accounting Standard
Disclosure of subsidiaries [abstract]
Other temporary differences, assets
Deductible temporary differences for which no deferred tax asset is recognised
Disposals
Disposals, intangible assets and goodwill
Disposals, intangible assets and goodwill
Entity Address, Address Line One
Total financial liabilities
Financial liabilities
Total financial liabilities
Non-current derivative financial liabilities
Derivative liabilities
Categories of non-current financial assets [abstract]
Classified in the statement of financial position
Document Annual Report
Royalty payment beginning period
Royalty payment beginning period
Royalty payment beginning period.
Leases
Disclosure of leases [text block]
Inventories
Disclosure of inventories [text block]
Disclosure Of Warrant Activity [line items]
Disclosure Of Warrant Activity [line items]
Disclosure Of Warrant Activity [line items]
Board members of group [member]
Board members of group.
Attribution of expenses by nature to their function [axis]
Warrants Granted 2012 Until November 2021 [member]
Warrants Granted 2012 Until November 2021 [Member]
Warrants Granted 2012 Until November 2021 [Member]
Foreign exchange translation
Increase (decrease) through net exchange differences, intangible assets and goodwill
Major business combination [member]
Major business combination [member]
Percentage of reasonably possible increase in unobservable input, liabilities
Key management personnel of entity or parent [member]
Key management personnel of entity or parent [member]
Summary of Fair Values for Warrant Grants
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
Investing activities
Cash flows from (used in) investing activities [abstract]
Address Type [Domain]
Asia [member]
Asia [Member]
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice provided on or prior to period as buyout amount
Amount Multiplied to Purchase Price Minus Revenue Interest Payments Paid to Purchaser on Effective Date of Buy-out Notice Provided on or Prior to Period as Buyout Amount.
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice provided on or prior to period as buyout amount.
Disclosure of summary of significant accounting policies [table]
Disclosure of summary of significant accounting policies [table]
Disclosure of summary of significant accounting policies [table]
Financial liabilities at fair value through profit or loss
Total financial liabilities at fair value through profit or loss
Financial liabilities measured at fair value through profit or loss
Conversion rate per note
Conversion Rate Per Note
Conversion rate per note.
Total current liabilities
Current liabilities
Current liabilities
Current liabilities
Current assets
Current assets [abstract]
Other Liabilities
Disclosure of other liabilities [text block]
Basis of Preparation
Disclosure of basis of preparation of financial statements [text block]
Ascendis Pharma Nordics A/S [member]
Ascendis Pharma Nordics A/S.
Currency [Axis]
Borrowings [member]
Long-term borrowings [member]
Company
Name of associate
Auditor Name
Sale of clinical supply
Revenue From Sale Of Clinical Supply
Revenue from sale of clinical supply.
Disclosure of general information.
Disclosure of General Information [Abstract]
Plant and machinery [member]
Plant and machinery [member]
Plant and machinery.
Capital increase
Increase (decrease) through transactions with owners, equity
Employee costs
Disclosure of employee benefits [text block]
U.S. dollars [member]
U.S. dollars [member]
U.S. dollars [member]
External credit grades [axis]
External credit grades [axis]
Related party transactions [abstract]
Entity Filer Category
Schedule of Asset's Expected Useful Life
Description of accounting policy for depreciation under property, plant and equipment explanatory
Description of accounting policy for depreciation under property, plant and equipment. [Refer: Property, plant and equipment]
Selling, General and Administrative Expenses
Description of accounting policy for expenses [text block]
Minimum beneficial ownership
Name of joint operation
Financial assets measured at amortized cost
Financial assets at amortised cost
Non-adjusting events after reporting period [member]
Non-adjusting events after reporting period [member]
Process plant and machinery [member]
Process plant and machinery [member]
Process plant and machinery [member]
Increase (decrease) through financing cash flows, liabilities arising from financing activities
Additions
Entity Current Reporting Status
Year of grant
Year of grant of warrants
Year of grant of warrants.
Additions
Additions other than through business combinations, intangible assets other than goodwill
American depository shares [member]
American depository shares.
Swiss franc to euro member.
Swiss Franc to Euro [Member]
Swiss franc to Euro [member]
Summary of Significant Accounting Policies
Disclosure of significant accounting policies [text block]
Finance income
Finance Income [Abstract]
Finance income.
Other Liabilities
Description Of Accounting Policy For Other Payables Explanatory [Text Block]
Description of accounting policy for other payables explanatory.
ICFR Auditor Attestation Flag
Foreign Currency Translation Reserve [member]
Reserve of exchange differences on translation [member]
Selling, general and administrative expenses [member]
Selling General And Administrative Expense [Member]
Acquired from third-parties (Nominal value)
Purchase Of Treasury Shares Nominal Value
Purchase of treasury shares nominal value.
Acquired from third-parties (Nominal values)
Property, Plant and Equipment
Description of accounting policy for property, plant and equipment [text block]
Minimum number of collaboration partner [Axis]
Minimum Number of Collaboration Partner.
Description of accounting policy for convertible notes and embedded derivative liabilities.
Description Of Accounting Policy For Convertible Notes And Embedded Derivative Liabilities [Policy Text Block]
Convertible Senior Notes and Embedded Derivative Liabilities
Summary of Principal Accountant Fees and Services
Disclosure of Detailed Information For Principal Accountant Fees and Service Explanatory [Text Block]
Disclosure of detailed information for principal accountant fees and service explanatory.
Summary of Depreciation Charges
Disclosure of detailed information about depreciations charges
Disclosure of detailed information about depreciations charges.
Hedging instruments [axis]
Summary of Number of Shares
Disclosure of classes of share capital [text block]
Disclosure Detailed Information About Marketable Securities [Table]
Disclosure detailed information about marketable securities table.
Text block [abstract]
UnableToMigrateMatchesIfrsTextblock[abstract]
Text block [abstract]
Funding received in exchange of royalty payments
Funding received in exchange of royalty payments
Funding received in exchange of royalty payments.
Disclosure of detailed information about borrowings [table]
Trade payables
Trade payables and accrued expenses
Major components of tax expense (income) [abstract]
Non-current portion of non-current borrowings
Total non-current portion of non-current borrowings
Borrowings
Software
Description of accounting policy for intangible assets other than goodwill [text block]
Level 2 of fair value hierarchy [member]
Level 2 [member]
Pensions (defined contribution plans)
Post-employment benefit expense in profit or loss, defined benefit plans
Total post-employment benefit expense in profit or loss, defined benefit plans
Weighted Average Duration Of Marketable Securities Current Explanatory
Weighted average duration of marketable securities current.
Weighted average duration of marketable securities current
Summary of Foreign Currency Sensitivity Analysis
Disclosure of foreign currency sensitivity analysis explanatory [text block]
Disclosure of foreign currency sensitivity analysis explanatory [text block]
Financial liabilities at amortised cost, class [member]
Financial liabilities at amortised cost, class [member]
Net proceeds from follow-on public offerings
Proceeds from issuing shares
Liabilities arising from financing activities
Beginning of period
End of period
Depreciation charge
Depreciations charges
Depreciation, property, plant and equipment
Level 3 of fair value hierarchy [member]
Level 3 [member]
Entity Emerging Growth Company
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Financial assets, category [member]
Financial assets, category [member]
Sales milestones received
Sales Milestones Received
Sales milestones received.
Additional tax deductions
Tax effect of deductible items not expensed
Tax effect of deductible items not expensed.
Increase/(decrease) in provisions
Adjustments for provisions
Categories of financial assets [axis]
Categories of financial assets [axis]
Components of equity [axis]
Components of equity [axis]
Antidilutive Securities Not Included In Diluted Earnings Per Share [Member]
Antidilutive securities not Included In diluted earnings per share.
Amortization
Adjustments for amortisation expense
Summary of Weighted Average Exercise Prices and Movements in Warrants
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
Net proceeds from borrowings
Proceeds from borrowings, classified as financing activities
Counterparties [axis]
Borrowings, maturity
Warrants outstanding
Dilutive effect of convertible instruments on number of ordinary shares
Average number of employees
Average number of employees
Acquisitions of treasury shares, net of transaction costs
Payments to acquire or redeem entity's shares
Reimbursement for acquisition of property, plant and equipment
Reimbursement From Acquisition of Property Plant and Equipment
Reimbursement from acquisition of property, plant and equipment.
Disclosure of sharebased payment arrangements.
Disclosure Of Sharebased Payment Arrangements [Abstract]
Europe [Member]
Europe [member]
Cash and Cash Equivalents
Description of accounting policy for determining components of cash and cash equivalents [text block]
Contractual commitments
Contractual capital commitments
Entity Voluntary Filers
Number of additional shares granted
Number Of Additional Shares Granted
Number of additional shares granted.
Disclosure of commitments and contingencies [line items]
Disclosure of commitments and contingencies [line items]
Disclosure of detailed information about property, plant and equipment [abstract]
Disclosure of changes in accounting estimates [abstract]
Document Transition Report
Increase decrease in derivative financial liabilities fair value
Total increase (decrease) in credit derivative, fair value
Increase (decrease) in credit derivative, fair value
Right-of-use assets [member]
Right-of-use assets [member]
Right-of-use assets [member]
Operating profit/(loss)
Profit (loss) from operating activities
Cash flows from/(used in) operating activities
Cash flows from (used in) operating activities
Net cash flows from (used in) operating activities
Deferred tax asset, not recognized
Tax Effect From Deferred Tax Asset Not Recognized
Tax Effect From Deferred Tax Asset, Not Recognized.
Contract liabilities [abstract]
Commitment from investors
Capital commitment from investors
Capital commitment from investors.
Marketable securities
Current financial marketable securities
Current financial assets available-for-sale
Vesting of shares.
Vesting Of Shares [Axis]
Entity Common Stock, Shares Outstanding
Fair value gains, derivatives
Gains on change in fair value of derivatives
Zero Coupon [Member]
Zero Coupon [Member].
Zero Coupon [Member]
Share repurchase program, Number of shares authorized to be repurchased
Share Repurchase Program Number Of Shares Authorized To Be Repurchased
Share repurchase program, Number of shares authorized to be repurchased.
Equity
Equity [abstract]
Disclosure of changes in accounting estimates [line items]
Disclosure of changes in accounting estimates [line items]
Total assets
Assets
Assets at beginning of period
Assets at end of period
Summary of Tax on Profit/Loss and Deferred Tax
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]
Income taxes received/(paid)
Income taxes paid (refund), classified as operating activities
Income taxes refund (paid)
Statement of changes in equity [abstract]
Entity's total for associates [member]
Entity's total for associates [member]
Disclosure of geographical areas [abstract]
Revenue (geographical)
Disclosure of financial instruments by type of interest rate [line items]
Timing of transfer of goods or services [member]
Reversals and other adjustments
Reversals and other adjustments, provisions
Reversals and other adjustments, provisions.
Royalty Pharma [member]
Royalty Pharma [member]
Royalty Pharma.
Danish Kroner (DKK) [member]
Denmark, Kroner
Document Information [Line Items]
Borrowings, interest rate
Borrowings, interest rate
Outstanding convertible notes, coupon fixed rate
Impairment of property, plant and equipment
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment
US Government Bonds [Member]
US Government Bonds [Member]
U.S. Government Bonds [Member].
Entity Registrant Name
Classes of other provisions [axis]
Disclosure Of Information About Marketable Securities Specified By Investment Grade Credit Rating Explanatory [Table Text Block]
Disclosure of information about marketable securities specified by investment grade credit rating explanatory.
Schedule Of Marketable Securities Specified By Investment Grade Credit Rating
Disclosure of changes in accounting estimates [table]
Disclosure of changes in accounting estimates [table]
Total comprehensive income/(loss)
Comprehensive income
Total comprehensive income
Effect of exchange rate changes on balances held in foreign currencies
Effect of exchange rate changes on cash and cash equivalents
Performance Stock Unit Program [Member]
Performance Stock Unit Program [Member]
Performance stock unit program member.
Deferred tax asset, not recognized
Deferred tax asset not recognized
Deferred tax asset, not recognized.
Treasury shares transferred under stock incentive program nominal value.
Treasury Shares Transferred Under Stock Incentive Program Nominal Value
Transferred under stock incentive programs (Nominal Value)
Disclosure of summary of significant accounting policies [abstract]
Disclosure of summary of significant accounting policies [abstract]
Total employee costs
Employee benefits expense
Employee benefits expense
Total employee costs
Disclosure of operating segments [abstract]
Financial assets, class [member]
Financial assets, class [member]
Title of 12(b) Security
Employees and consultants [member]
Employees and Consultants [Member]
Employees and consultants.
Condensed Income Statement [Table]
Statement of comprehensive income, profit or loss location [member]
Statement of comprehensive income, profit or loss location [member]
Statement of comprehensive income, profit or loss location 1.
Cash flows generated from/(used in) operations
Cash flows from (used in) operations
Net cash flows from (used in) operations
Events After Reporting Period [member]
Events after reporting period.
Disclosure of beneficial ownership [line items]
Disclosure Of Beneficial Ownership [line items]
Disclosure Of Beneficial Ownership [line items]
Number of Warrants, Outstanding
Beginning balance
Ending balance
Number of other equity instruments outstanding in share-based payment arrangement
Share-based Payment
Disclosure of share-based payment arrangements [text block]
Borrowings condition for redemption
Borrowings Condition For Redemption
Borrowings condition for redemption.
Disclosure Of Beneficial Ownership [abstract]
Disclosure Of Beneficial Ownership [abstract]
Property, plant and equipment [member]
Property, plant and equipment [member]
Document Type
Intangible Assets
Disclosure of intangible assets [text block]
Research and development costs
Research and development expense
Entity's total for related parties [member]
Entity's total for related parties [member]
Summary of Inventories Explanatory
Disclosure of Quantitative Information about Inventories Explanatory [Table Text Block]
Disclosure of quantitative Information about inventories explanatory.
USA [member]
UNITED STATES
Disclosure of reconciliation of liabilities arising from financing activities [table]
Subsidiaries [axis]
Subsidiaries [axis]
Profit/(loss) before tax
Accounting profit
Entity Shell Company
Social security costs
Social security contributions
Ascendis Pharma UK Limited [member]
Ascendis Pharma UK Limited.
Classes of intangible assets and goodwill [axis]
Income taxes refund
Income taxes paid (refund)
Total income taxes paid (refund)
Tax for the year can be explained as follows:
Profit loss before income tax [abstract]
Profit loss before income tax.
Summary of significant accounting policies.
Summary of Significant Accounting Policies [abstract]
Expense relating to short-term leases for which recognition exemption has been used
Short term leases and leases of low value assets
Other liabilities
Other current liabilities
Company's share of equity before eliminations
Share of equity before eliminations
Share of equity before eliminations.
Ascendis Pharma Iberia S.L. [member]
Ascendis Pharma Iberia S L [Member]
Ascendis Pharma Iberia S.L.
Receivables
Adjustments for decrease (increase) in trade and other receivables
Share price
Share Price Applied For Valuation
Share price applied for valuation.
Treasury shares
Treasury shares
Beginning balance (Nominal value)
Ending balance (Nominal Value)
Nominal amount of treasury shares
Bottom of range [member]
Bottom of range [member]
Disclosure of reconciliation of liabilities arising from financing activities [text block]
Summary of Development in Borrowings Related to Financing Activities
North America [member]
North America [Member]
Number of persons
Number of employees1
Number of employees1.
Additional Office Facility [Member]
Additional office facility.
Multiple of the purchase price were royalty payment will cease
Multiple Of Purchase Price, Were Royalty Payment Will Cease
Multiple of purchase price, were royalty payment will cease.
Total lease expenses
Lease Expenses
Lease expenses.
Marketable Securities
Marketable Securities Explanatory
Marketable securities explanatory.
Security Exchange Name
Lease liabilities [abstract]
Current financial assets
Total current financial assets
Current assets
Profit/(loss) before tax
Equity before tax
Gains (losses) on change in value of foreign currency basis spreads, before tax
Disclosure Of Beneficial Ownership [table]
Disclosure Of Beneficial Ownership [table]
Disclosure Of Beneficial Ownership [table]
Liquidity risk [member]
Liquidity risk [member]
Subsequent Events
Disclosure of events after reporting period [text block]
Liabilities [member]
Financial assets at fair value, class [member]
Financial assets at fair value, class [member]
Document Registration Statement
Foreign exchange translation
Increase (decrease) through net exchange differences, property, plant and equipment
Asset's expected useful life
Useful life measured as period of time, property, plant and equipment
Associates [axis]
Associates [axis]
Classes of financial assets [axis]
Classes of financial assets [axis]
Fair value of royalty funding liabilities
Fair Value of Royalty Funding Liabilities
Fair value of royalty funding liabilities.
Disclosure of non-adjusting events after reporting period [line items]
Derivative financial liabilities
Derivative liabilities
Beginning balance
Ending balance
Carrying amount of royalty funding liabilities
Carrying Amount of Royalty Funding Liabilities
Carrying amount of royalty funding liabilities.
Within 1 year [member]
Not later than one year [member]
Trade Payables and Accrued Expenses
Description of accounting policy for trade and other payables [text block]
Convertible Senior Notes [Member]
Convertible senior notes [Member].
Convertible senior notes [Member]
Entity Address, Country
Contact Personnel Name
Fixed interest rate [Member]
Fixed interest rate [member]
Coupon fixed rate structure [member]
Cost of sales [member]
British pounds to Euro [member]
British pounds to Euro [member]
British pounds to Euro.
Disclosure of detailed information about financial instruments [table]
Disclosure of detailed information about financial instruments [table]
Number of reportable segment
Number of reportable operating segments
Number of reportable operating segments.
Current tax expense (income) and adjustments for current tax of prior periods
Current tax expense (income) and adjustments for current tax of prior periods
Total current tax expense (income) and adjustments for current tax of prior periods
Expected volatility
Expected volatility, share options granted
Number of additional shares authorized to grant
Number of Additional Shares Authorized to Grant
Number of additional shares authorized to grant.
Disclosure of non-adjusting events after reporting period [table]
Disclosure of quantitative information about right-of-use assets [abstract]
Classes of financial instruments [axis]
Research and Development Costs
Description of accounting policy for research and development expense [text block]
Minimum [Member]
Minimum [Member]
Income Statement [Domain]
Income Statement [Domain]
Income statement.
China [member]
CHINA
Ascendis Pharma Endocrinology GmbH.
Ascendis Pharma Endocrinology GmbH [Member]
Ascendis Pharma Endocrinology GmbH [member]
Sharebased Payment Arrangement, Award type [Domain]
Share-based payment arrangement, award type.
Derivative financial liabilities at fair value remeasurement recognized in financial income or expense.
Derivative Financial Liabilities at Fair Value Remeasurement Recognized in Financial Income Or Expense
Remeasurement recognized in financial income or expense
Risk-free interest rate
Risk free interest rate, share options granted
Assets
Assets [abstract]
Performance Stock Units [Member]
Performance Stock Units [Member]
Performance stock units.
Intangible assets
Intangible assets at beginning period
Intangible assets at ending period
Intangible assets and goodwill
Total intangible assets and goodwill
Maturity [axis]
Granted during the period
Granted during the year
Number of Warrants, Granted
Disclosure of voluntary change in accounting policy [abstract]
VISEN Pharmaceuticals
Associate [abstract]
Associate [abstract]
Nominal positions (net)
Notional amount
Principal amount
Ordinary shares [member]
Ordinary shares [member]
Total Deferred Tax Assets/(Liabilities) at December 31
Net deferred tax assets
Share-based Payment Reserve [member]
Reserve of share-based payments [member]
Ownership
Proportion of ownership interest in subsidiary
Royalty Funding Liabilities
Description of Accounting Policy for Royalty Funding Liabilities [Text Block]
Description of accounting policy for royalty funding liabilities text block.
Description of basis of consolidation.
Description Of Basis Of Consolidation [text block]
Basis of Consolidation
Provisions
Description of accounting policy for provisions [text block]
Ascendis Pharma, Inc [member]
Ascendis Pharma, Inc. [member]
Ascendis Pharma, Inc..
Disclosure of subsidiaries [table]
Disclosure of subsidiaries [table]
Types of risks [axis]
Types of risks [axis]
Deferred tax, adjustments to prior years
Adjustments for deferred tax of prior periods
Carrying amount [member]
Carrying amount [member]
Sale of commercial products
Revenue from sale of goods
2025
Two thousand and twenty five [Member]
Two thousand and twenty five.
Number of commercial customers
Number of commercial customers.
Work in progress
Current work in progress
Reversal of finance income
Total finance income
Finance income
Finance income
Other receivables
Other receivables
2024
Two Thousand And Twenty four [Member]
Two thousand and twenty four.
Entity Central Index Key
Changes in Accounting Policies
Disclosure of changes in accounting policies [text block]
Share Price Measurement Input [Member]
Share price measurement input [member].
Lower Medium Grade [Member]
Lower medium grade.
Disclosure of employee compensation costs [table]
Disclosure of employee compensation costs [table]
Disclosure of employee compensation cost.
Denmark [member]
Country of domicile [member]
Gross carrying amount [member]
Gross carrying amount [member]
Disclosure of quantitative information about right-of-use assets [line items]
Disclosure of classes of share capital [abstract]
Summary of Investments in Group Enterprises
Disclosure of subsidiaries [text block]
Additions
Additions other than through business combinations, property, plant and equipment
Trade receivables
Current trade receivables
Milestones [Member]
Milestones [Member]
Milestones member.
Disclosure of financial risk management [text block]
Financial Risk Management
Consolidation Principles Subsidiaries
Description of accounting policy for subsidiaries [text block]
Upper Medium Grade [Member]
Upper medium grade.
Classification Of Related Party [Domain]
Classification Of Related Party [Domain]
Disclosure of detailed information about property, plant and equipment [table]
Disclosure of detailed information about property, plant and equipment [table]
Ascendis Pharma GmbH [member]
Ascendis Pharma GmbH [member]
Ascendis Pharma GmbH.
Other provisions [member]
2023
Two Thousand And Twenty Three [Member]
Two thousand and twenty three.
Proportion of voting rights held in associate
Percentage of warrants vested
Percentage Of Warrants Vested
Percentage of warrants vested.
Transferred
Increase (decrease) through transfers, property, plant and equipment
Disclosure of summary of fair value hierarchy.
Disclosure of Summary of Fair Value Hierarchy [Table Text Block]
Summary of Fair Value Hierarchy
Warrants [member]
Warrant1 [member]
Warrants.
U.S. SKYTROFA [member]
United States Skytrofa [member]
U.S. SKYTROFA.
Disclosure Of Holding Of Treasury Shares [Table]
Disclosure of holding of treasury shares.
Revenue [table]
Revenue table.
Settlement of marketable securities
Proceeds from disposal or maturity of available-for-sale financial assets
Contract liabilities
Contract liabilities at beginning of period
Contract liabilities at end of period
Total contract liabilities
Document Information [Table]
Company
Name of subsidiary
Trade payables
Contractual Undiscounted Cashflow Of Trade Payables And Other Payables
Contractual undiscounted cashflow of trade payables and other payables.
Current tax (expense)/income
Current tax expense (income)
Investments accounted for using equity method [abstract]
Disclosure of detailed information about depreciations charges [Line Items]
Increase decrease in treasury shares transferred under stock incentive program.
Increase Decrease In Treasury Shares Transferred Under Stock Incentive Program
Transferred under stock incentive programs (Holding)
Expected life of warrants (years)
Option life, share options granted
Collaboration partners and license agreements [Member]
Collaboration partners and license agreements [Member]
Collaboration Partners and License Agreements.
Prime1.
Prime1 [Member]
Prime [Member]
Disclosure of fair value measurement of liabilities [line items]
Ascendis Pharma Endocrinology, Inc. [member]
Ascendis Pharma Endocrinology Inc [Member]
Funding received in exchange of royalty payments
Funding received in exchange
Funding Received In Exchange
Funding received in exchange.
Finance expenses
Total finance expenses
Reversal of finance expenses
Finance costs
Finance costs
Weighted Average Life, Granted
Weighted average remaining contractual life of outstanding other equity instruments
Weighted average remaining contractual life of outstanding other equity instruments
Weighted average remaining life for outstanding warrants
Payment of withholding taxes under stock incentive programs
Payment Of Withholding Taxes Under Stock Incentive Programs
Payment of withholding taxes under stock incentive programs.
Financial marketable securities
Financial assets available-for-sale
Expected Lease Commence Year
Expected lease commence year.
Expected Lease Commence Year
Borrowings threshold consecutive trading days for redemption
Borrowings Threshold Consecutive Trading Days For Redemption
Borrowings threshold consecutive trading days for redemption.
Avoro Capital Advisors LLC [member]
Avoro Capital Advisors LLC [Member]
Avoro Capital Advisors LLC.
New IFRS Accounting Standards Not Yet Effective
Disclosure of initial application of standards or interpretations [text block]
Condensed Income Statements, Captions [Line Items]
Contract liabilities (deferred income)
Total adjustments for increase (decrease) in deferred income including contract liabilities
Adjustments for increase (decrease) in deferred income including contract liabilities
Entity Interactive Data Current
Granted In 2021 [Member]
Granted In 2021 [Member]
Granted In 2021 [Member]
Accumulated Deficit [member]
Retained earnings [member]
Non-current assets
Non-current assets [abstract]
Restricted Stock Units [Member]
Restricted stock units.
Disclosure of summary of significant accounting policies [line items]
Disclosure Of Summary Of Significant Accounting Policies [line items]
Line items representing the disclosure of summary of significant accounting policies.
Disclosure of intangible assets, and property, plant and equipment
Disclosure of operating segments [text block]
Nonexecutivesenior management [Member]
Non-executive Senior Management.
Share-based payment (Note 7)
Increase (decrease) through share-based payment transactions, equity
Local Phone Number
Licenses [Member]
Licenses [Member]
Licenses member.
Capital commitments [abstract]
Revenue recognized from contract liabilities
RevenueRecognizedFromContractLiabilities
Revenue recognized from contract liabilities.
Ascendis Pharma Growth Disorders A/S [member]
Ascendis Pharma Growth Disorders AS [member]
Ascendis Pharma growth disorders AS.
Vesting specified by date
Exercised during the year
Number of other equity instruments exercised or vested in share-based payment arrangement
Forfeited during the year
Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement
Interest rate risk [member]
Interest rate risk [member]
Ranges [member]
Ranges [member]
Short-term marketable securities.
Short Term Marketable Securities
Short-term marketable securities
Provisions
Disclosure of provisions [text block]
Payment of principal portion of lease liabilities
Payments of lease liabilities, classified as financing activities
Payments of lease liabilities
Foreign Currency Risk [domain]
Foreign Currency Risk [domain]
Foreign currency risk domain.
Classification Of Related Party [Axis]
Classification Of Related Party [Axis]
Commitments and Contingencies
Disclosure of commitments and contingent liabilities [text block]
Disclosure of employee compensation costs [abstract]
Disclosure of employees compensation costs.
Office Facility [Member]
Office facility.
Unobservable inputs [member]
Document Shell Company Report
Deferred revenue from associate
Deferred Revenue From Associate
Deferred revenue from associate.
Liabilities arising from financing activities [axis]
Liabilities arising from financing activities [axis]
Types of share-based payment arrangements [axis]
Types of share-based payment arrangements [axis]
Development in Level 3 Fair Value Remeasurements
Disclosure Of Development In Level Three Fair Value Measurements Explanatory
Disclosure of development in level three fair value measurements.
Prior year adjustments
Tax Effects from Prior Year Adjustment
Tax effects from prior year adjustment.
All Currencies [Domain]
Range [axis]
Range [axis]
Intangible assets and goodwill [member]
Convertible notes
Potential Conversion Of Convertible Senior Notes Into Number Of Ordinary Shares
Potential conversion of convertible senior notes into number of ordinary shares.
Finance expenses paid
Finance costs paid, classified as operating activities
Disclosure Of Commitments And Contingencies [table]
Disclosure Of Commitments And Contingencies [table]
Document Fiscal Year Focus
Within 1 to 5 years [member]
Later than one year and not later than five years [member]
Types of interest rates [axis]
Types of interest rates [axis]
Finance expenses
Finance Expenses [Abstract]
Finance expenses.
Minimum beneficial ownership percentage
Minimum Beneficial Ownership Percentage
Minimum beneficial ownership percentage.
Leasehold improvements [member]
Leasehold improvements [member]
Ownership
Disclosure Of Beneficial Ownership [text block]
The entire disclosure of beneficial ownership explanatory.
At fair value [member]
Fair value [member]
Hedging instruments [member]
Disclosure Of Marketable Securities Specified By Investment Grade Credit Rating [Table]
Disclosure of marketable securities specified by investment grade credit rating.
Disclosure of deiailed information about development in provisions.
Summary of Development in Provisions
Disclosure of Detailed Information About Development in provisions [Explanatory]
Foreign currency target percentage
Foreign Currency Target Percentage
Foreign Currency Target Percentage
Disclosure of performance obligations [line items]
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice as buyout amount
Amount Multiplied to Purchase Price Minus Revenue Interest Payments Paid to Purchaser on Effective Date of Buy-out Notice As Buyout Amount
Amount multiplied to purchase price minus revenue interest payments paid to purchaser on effective date of buy-out notice as buyout amount.
Financial liabilities, class [member]
Financial liabilities [member]
Convertible senior notes
Notes and debentures issued
Segment Information
Disclosure of entity's operating segments [text block]
Cash and cash equivalents at January 1
Cash and cash equivalents
Cash and cash equivalents at December 31
Cash and cash equivalents
Total cash and cash equivalents
Aggregated measurement [member]
Number Of Treasury Shares Outstanding
Number of treasury shares outstanding.
Ending balance (Holding)
Beginning balance (Holding)
Additional tax deductions, determined by annual warrants exercises by employees
Additional Tax Deduction
Additional tax deduction.
Classes of liabilities [axis]
Distributable equity
Distributable equity
Distributable equity.
Increase decrease in derivative financial liabilities fair value
Increase Decrease In Derivative Financial Liabilities Fair Value
Increase decrease in derivative financial liabilities fair value.
Additions
Forfeited during the period
Forfeited during the year
Number of other equity instruments forfeited in share-based payment arrangement
Tax deductible losses
Tax effect of tax losses
Minimum beneficial ownership
Major persons or groups of affiliated persons holding minimum beneficial ownership
Major persons or groups of affiliated persons holding minimum beneficial ownership.
Additional development and regulatory milestones potentially to be received
Additional Development and Regulatory Milestones Received
Additional development and regulatory milestones
Risks [member]
Risks [member]
Non-deductible costs
Tax effect of expense not deductible in determining taxable profit (tax loss)
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]
Entities affiliated with Janus Henderson Group plc [member]
Entities Affiliated With Janus Henderson Group plc [Member]
Entities affiliated with Janus Henderson Group plc.
Share Capital [member]
Issued capital [member]
Issued Capital [member]
Levels of fair value hierarchy [axis]
Disclosure of associates [line items]
Floating interest rate [member]
Other employee costs
Other employee expense
Fair value of warrants granted in the year
Fair Value Of Warrants Granted
Fair Value Of Warrants Granted
Amortization and impairment [member]
Accumulated impairment [member]
Classes of share capital [axis]
Classes of share capital [axis]
Other comprehensive income/(loss), net of tax
Other comprehensive income/(loss) for the year, net of tax
Other comprehensive income that will be reclassified to profit or loss, net of tax
Maximum additional development and regulatory milestones potentially to be received
Maximum additional development and regulatory milestones potentially to be received.
Derivatives [member]
Classes of financial liabilities [axis]
Intangible assets
Description of accounting policy for intangible assets and goodwill [text block]
Warrant compensation cost
Warrant Compensation Cost
Warrant compensation cost.
Non-current liabilities
Non-current liabilities [abstract]
Top of range [member]
Top of range [member]
Foreign Currency Conversion Option [Member]
Foreign Currency Conversion Option.
Accretion of interest
Lease interest
Tax effect of:
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]
Statement of changes in equity [table]
Weighted average fair value at measurement date, other equity instruments granted
Fair Value of Other Equity Instruments Granted
Increase Decrease In Foreign Currency Exchange Rate
Increase decrease in foreign currency exchange rate.
Increase in foreign currency exchange rate
Disclosure Of Holding Of Treasury Shares [Abstract]
Disclosure of holding of treasury shares.
Cover [Abstract]
New IFRSs [member]
New IFRSs [member]
Weighted average share price
Weighted average share price
Assets [member]
Assets [member]
Schedule of Revenue Recognized in Consolidated Statement of Profit or Loss
Disclosure of segment revenues by destination of major customers explanatory
Disclosure of segment revenues by destination of major customers explanatory.
Entities affiliated with Wellington Management Group LLP [Member]
Entities Affiliated With Wellington Management Group LLP [Member]
Entities Affiliated With Wellington Management Group LLP.
Insider Trading Policies and Procedure [Line Items]
Insider Trading Policies and Procedure [Line Items]
Inventories [Abstract]
Inventories.
Measurement [axis]
Proceeds from exercise of warrants
Proceeds from exercise of warrants
Proceeds from exercise of warrants
Insider Trading Policies and Procedure [Table]
Insider Trading Policies and Procedure [Table]
Exchange differences on translating foreign operations
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
Finished goods
Current finished goods
Contract Liabilities [Table]
Contract liabilities [Table].
Non-adjusting events after reporting period [axis]
Non-adjusting events after reporting period [axis]
Total current assets
Current assets
Current assets
Raw materials and consumables
Current raw materials and current production supplies
Total current raw materials and current production supplies
Maximum [Member]
Maximum [Member]
Total liabilities
Liabilities
Liabilities at beginning of period
Liabilities
Liabilities at end of period
Total liabilities
Additions
Additions To Lease Liabilities
Additions To Lease Liabilities.
Going Concern
Disclosure of going concern [text block]
Current liabilities
Current liabilities [abstract]
Goodwill [member]
Goodwill [member]
Disclosure of reconciliation of liabilities arising from financing activities [abstract]
Upfront payment received
Upfront Payment Received
Upfront payment received.
Deferred tax liabilities
Deferred tax liabilities
Increase (decrease) through effect of repayments, liabilities arising from financing activities.
Increase Decrease Through Effect Of Repayments, Liabilities Arising From Financing Activities
Repayments
Percentage of ownership in the customer company
Ownership
Proportion of ownership interest in associate
Income Taxes
Description of accounting policy for income tax [text block]
Reversal of gain and loss on disposal of property, plant and equipment
Reversal of gain and loss on disposal of property, plant and equipment
Gains (losses) on disposals of property, plant and equipment
Net gains (losses) on disposals of property, plant and equipment
Disclosure of associates [table]
Disclosure of associates [table]
Entity's total for external credit grades [member]
Entity's total for external credit grades [member]
Equity [member]
Equity [member]
Borrowings redemption period
Borrowings Redemption Period
Borrowings redemption period.
Disclosure of subsidiaries [line items]
Disclosure of subsidiaries [line items]
Changes in working capital:
Changes in working capital [abstract]
Changes in working capital.
Lease liabilities
Contractual Undiscounted Cashflow Of Financial Lease Liabilities
Contractual undiscounted cashflow of Financial lease liabilities.
Other receivables
Other non-current receivables
Ascendis Pharma Oncology Division AS [member]
Ascendis Pharma Oncology Division AS [Member]
Ascendis Pharma On cology Division AS Member
Percentage of each tranche directly attributable to accomplishment of financial results achieved in financial year prior to vesting date
Percentage of Each Tranche Directly Attributable to Accomplishment of Financial Results Achieved in Financial Year Prior to Vesting Date
Percentage of each tranche directly attributable to accomplishment of financial results achieved in financial year prior to vesting date.
Revenue interest payment in percentage in exchange for funding
Exchange Rate For Percentage Of Revenue To Royalty Payment
Exchange rate for percentage of revenue to royalty payment.
Weighted average exercise price
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement
Statement of changes in equity [line items]
Statement [LineItems]
Number of persons
Number of employees
Total equity and liabilities
Equity and liabilities
Royalties and Milestones [Member]
Royalties and Milestones [Member]
Royalties and milestones.
Share-based payment
Adjustments for share-based payments
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of terms and conditions of share-based payment arrangement [table]
Disclosure of detailed information about intangible assets [table]
Disclosure of detailed information about intangible assets [table]
Total inventories
Inventories
Consideration received
Consideration paid (received)
Performance obligations [axis]
Total principal accountant fees and services
Auditor's remuneration
Credit risk [member]
Impact from associate
Tax Effects From Impacts From Associates
Tax effects from impacts from associates.
Treasury shares [member]
Summary of Inventory Disclosure [Line Items]
Summary of inventory disclosure.
Share-based payment arrangements [member]
Share-based payment arrangements [member]
Foreign Currency
Description of accounting policy for foreign currency translation [text block]
Selling, general and administrative expenses
Selling, general and administrative expense
Total selling, general and administrative expense
Aggregated time bands [member]
Cost of sales
Cost of sales
Cost of sales
Changes in Accounting Policies and Disclosures
Description Of Accounting Policy For Changes In Accounting Policies and Disclosures [policy text block]
Description Of Accounting Policy For Changes In Accounting Policies and Disclosures [policy text block]
No Trading Symbol Flag
No Trading Symbol Flag
Other effects including effect of different tax rates
Other tax effects for reconciliation between accounting profit and tax expense (income)
Cost of capital increase
Costs of capital increase (decrease)
Costs of capital increase (decrease).
Sale of goods and services to associate
Sale of goods and services to associate.
Invoicing of goods and services to associate
Statement of comprehensive income, profit or loss location [axis]
Statement of comprehensive income, profit or loss location [axis]
Statement of comprehensive income, profit or loss location.
Trading Symbol
Allowance for Expected Credit Losses on Financial Assets
Disclosure of allowance for credit losses [text block]
Trade payables, accrued expenses and other payables
Adjustments for increase (decrease) in trade and other payables
Net settlement under stock incentive programs
Net settlement under stock incentive programs
Net settlement under stock incentive programs
Net settlement under stock incentive programs.
Equity and liabilities
Equity and liabilities [abstract]
Disclosure of detailed information about financial instruments [line items]
Disclosure of detailed information about financial instruments [line items]
Acquisition of property, plant and equipment
Purchase of property, plant and equipment, classified as investing activities
Purchase of property, plant and equipment
Disclosure of operating segments [table]
Disclosure of operating segments [table]
Other equipment [member]
Other equipment [Member]
Other equipment Member
US Treasury bills [Member]
US Treasury bills [Member]
U.S. Treasury bills [Member].
Marketable Securities
Description of accounting policy for available-for-sale financial assets [text block]
Deferred tax, movement for the year
Deferred Tax Movement for The Year
Deferred tax movement for the year.
Reversal of income taxes (expenses)
Tax on profit/(loss) for the year
Tax on profit/(loss) for the year
Tax expense (income)
Tax income (expense)
Total tax expense (income)
Customers [member]
Customers [member]
Share-based payment
Expense from share-based payment transactions with employees
Disclosure of investments accounted for using equity method [text block]
Schedule of Financial Information of Investment in VISEN
Entity Well-known Seasoned Issuer
Financial liabilities, category [member]
Financial liabilities, category [member]
Non-current financial assets
Total non-current financial assets
Non-current assets
Finance income received
Finance income received, classified as operating activities
Contract liabilities
Non-current contract liabilities
Total non-current contract liabilities
Total equity
Equity
Equity
Equity
Equity
Audit fees
Auditor's remuneration for audit services
Commercial Customers [Member]
Commercial customers [Member]
Commercial Customers.
Major customers [axis]
Major customers [axis]
Payment of principal portion of liabilities
Cash outflow for leases
Total lease cash-outflows
Financial liabilities at fair value, class [member]
Categories Of Shares Based Payments [Axis]
Categories Of Shares Based Payments [Axis]
Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities
Foreign exchange adjustment
Profit/(loss) before tax
Profit/(loss) before tax
Profit (loss) before tax
Tax at the Danish corporation tax rate of 22%
Tax expense (income) at applicable tax rate
Disclosure of operating segments [line items]
Disclosure of operating segments [line items]
Revenue
Financial assets at amortised cost, class [member]
Financial assets at amortised cost, class [member]